Who owns ImmunoGen?

Key details on ImmunoGen (Ticker: IMGN)

Who owns ImmunoGen?

Is IMGN a good stock to own? Find out who bought ImmunoGen, who sold ImmunoGen (IMGN) stock, and who holds a large position in ImmunoGen.

Fund Name Number of Shares Share Valuation As Of
ClearBridge Advisors 14.45M $129.34M March 31, 2015
PRIMECAP Management Company 12.87M $123.53M Sept. 30, 2015
Vanguard 12.22M $117.40M Sept. 30, 2015
FMR 7.26M $69.67M Sept. 30, 2015
First Trust Advisors 5.81M $61.55M Sept. 30, 2014
OrbiMed Advisors 3.59M $34.50M Sept. 30, 2015
Baker Bros. Advisors 3.55M $34.06M Sept. 30, 2015
BlackRock Fund Advisors 3.28M $31.50M Sept. 30, 2015
STATE STREET CORPORATION 3.23M $30.97M Sept. 30, 2015
Wellington Management Company 3.13M $46.68M March 31, 2014
BB Biotech AG 2.84M $25.43M March 31, 2015
BlackRock Institutional Trust Company, N.A. 2.29M $32.95M June 30, 2015
Sectoral Asset Management 2.27M $24.04M Sept. 30, 2014

Who sold ImmunoGen?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Dec. 31, 2013 2.37M $34.81M